is bpc 157 a glp 1 BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC-157 - LGI peptides
Description
The goal is not just to lose weight
Rybelsus (oral semaglutide) and injectable GLP-1 medications are the currently approved options
Up next will be GLP-1 medications and kidney disease, stay tuned for that
Previously, there had only been one oral drug for this indication: metformin, which was approved in 2000
